Novartis CEO Warns of Long-Term Implications of Trump's Drug Pricing Policy
Novartis CEO Vas Narasimhan warned that the long-term implications of Trump's drug pricing policy will become significant over the next 18 months. He emphasized the need for European and Japanese governments to adjust how they reward innovation to avoid delayed access to novel medicines for patients.
Tickers: $NVS
Topics: CEO statement drug pricing policy healthcare regulation Novartis